查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
急性肾损伤治疗市场 - 成长、未来前景、竞争分析，2024-2032 年
市场调查报告书
商品编码
1462358

急性肾损伤治疗市场 - 成长、未来前景、竞争分析，2024-2032 年

Acute Kidney Injury Treatment Market - Growth, Future Prospects and Competitive Analysis, 2024 - 2032
出版日期: | 出版商: Acute Market Reports | 英文 114 Pages | 商品交期: 最快1-2个工作天内

价格

受各种驱动因素和细分方面的影响，预计 2024 年至 2032 年预测期内，急性肾损伤治疗市场将以 7.8% 的复合年增长率增长。推动市场成长的三个主要因素包括急性肾损伤盛行率的增加、治疗方法的进步以及老年人口的增加。这些因素促成了市场的积极前景，对有效 AKI 治疗的需求预计将激增。竞争趋势、Fresenius Medical Care AG &Co.KGaA、Baxter International Inc. 的策略性举措（包括研发、合作伙伴关係和技术整合）支撑着充满活力和不断发展的市场。这些公司正在对自己进行策略性定位，以应对课题并利用新机遇，塑造急性肾损伤治疗市场的未来轨迹。

市场驱动因素

透析技术的进步

由于透析技术的不断进步，急性肾损伤治疗市场的透析部分正在经历显着增长。到 2023 年，对更有效率、对患者友善的透析方法的需求将激增。穿戴式和便携式透析机等技术创新已变得普遍，增加了 AKI 患者获得治疗的机会并提高了生活品质。事实证明，先进透析技术的采用与患者满意度的提高之间存在正相关关係。

更重视支持性护理

支持性护理已成为急性肾损伤治疗市场的关键驱动力，满足了全面患者管理的需求。超越传统医疗介入措施向整体病患照护的典范转移促进了支持性照护的兴起。到 2023 年，有证据表明，人们越来越认识到社会心理支持、营养干预和症状管理对于改善 AKI 患者预后的重要性。支持性护理策略不仅可以提高病人的福祉，而且还显示出成本效益的潜力。

依 AKI 类型细分

基于 AKI 类型（例如肾前性 AKI、原发性肾性 AKI 和肾后性 AKI）的市场区隔在客製化治疗方法方面发挥了至关重要的作用。2023 年，肾前性 AKI 领域的收入最高，反映了导致肾臟血流量减少的病理学的流行。同时，基本肾臟 AKI 部分在预测期内显示出最高的复合年增长率，这意味着对基本肾臟问题的认识和针对性干预措施有所提高。

AKI 后復原的课题

儘管急性治疗的进展值得注意，但市场在 AKI 后的恢復方面面临重大限制。到 2023 年，证据显示一些 AKI 患者在实现完全康復和预防慢性肾臟病进展方面取得的成功有限。儘管具有急性治疗功效，但长期影响和持续恢復仍然是医疗保健提供者和患者的担忧和课题。

依治疗划分的市场 透析疗法主导市场

市场主要分为透析治疗和支持性治疗。2023年，透析疗法成为主要的治疗方式，在2024-2032年的预测期内获得最高的收入并表现出最高的复合年增长率（CAGR）。透析治疗，包括血液透析和腹膜透析，在解决 AKI 相关併发症方面发挥重要作用，并为患者提供了重要的生命线。

依类型划分的市场：肾前性 AKI 细分市场占据主导地位

AKI分为不同类型，包括肾前性AKI、原发性肾性AKI及肾后性AKI。肾前性 AKI 是指导致肾臟血流量减少的疾病的盛行率，例如脱水和心臟衰竭，疾病在 2023 年的销售量最高。同时，重要的肾臟 AKI 领域在预测期内显示出最高的复合年增长率。这强调提高对急性肾小管坏死等基本肾臟问题的认识和有针对性的干预。

依最终用户划分的市场：医院主导市场

依最终用户细分包括医院、门诊手术中心 (ASC) 和其他医疗保健环境。到2023年，无论从收入或复合年增长率来看，医院都已成为主要的最终用户。医院在管理急性肾损伤病例、提供专门护理和获得先进治疗方面至关重要。门诊手术中心和其他医疗机构在某些情况下也发挥着重要作用，并为 AKI 治疗的整体格局做出了贡献。

北美仍处于世界领先地位

区域细分分析揭示了令人着迷的趋势，反映了 AKI 盛行率、医疗基础设施和治疗可近性的区域差异。在急性肾损伤治疗市场中，亚太地区的复合年增长率最高。这一增长是由于人们认识的提高、医疗保健基础设施的改善以及导致 AKI 的疾病盛行率的增加。该地区的医疗保健环境充满活力，将在未来 AKI 治疗中发挥重要作用。从销售比例来看，2023年北美市场将会领先。该地区的主导地位是由大量患者人口、完善的医疗设施以及积极主动的 AKI 管理方法等因素推动的。对于希望利用新机会并应对多元化医疗保健生态系统中的特定课题的利害关係人来说，瞭解区域细微差别至关重要。

预测期内市场竞争将加剧

2023年，急性肾损伤治疗市场将包括Fresenius Medical Care AG &Co.KGaA、Baxter International Inc.、B. Braun Melsungen AG、Angion Biomedica Corp.、AM-Pharma、Quark Pharmaceuticals, Inc.、Asahi Kasei Medical、LG Chem等。这些产业巨头正在策略性地实施研发、联盟和地理扩张等举措，以巩固其市场地位。值得注意的是，Fresenius Medical Care AG &Co.KGaA 专注于尖端技术，而 Baxter International 则专注于以患者为中心的方法。此外，B. Braun Melsungen AG 透过併购和品质改进等策略性举措为市场动态做出了重大贡献。这凸显了动态的市场格局和不断变化的竞争格局。

本报告回答的关键问题

影响急性肾损伤治疗市场成长的关键微观和宏观环境因素有哪些？

在目前和预测期内，有关产品细分和地区的主要投资领域有哪些？

2032 年之前的预估与市场预测

在预测期间内，哪个细分市场的复合年增长率最快？

哪个细分市场拥有较大的市场占有率，为什么？

低收入和中等收入国家是否正在投资急性肾损伤治疗市场？

急性肾损伤治疗市场最大的区域市场是哪一个？

亚太、拉丁美洲、中东/非洲等新兴市场的市场趋势与动态如何？

推动急性肾损伤治疗市场成长的主要趋势是什么？

主要竞争对手及其提高在全球急性肾损伤治疗市场占有率的关键策略是什么？

目录

第一章 前言

  • 报告内容
    • 报告目的
    • 目标听众
    • 主要报价
  • 市场细分
  • 调查方法
    • 第一阶段—二次调查
    • 第二阶段-初步调查
    • 第三阶段-专家评审
    • 先决条件
    • 采取的方法

第 2 章执行摘要

第三章急性肾损伤治疗市场：竞争分析

  • 主要厂商市场定位
  • 供应商采取的策略
  • 主要产业战略
  • 等级分析：2023 年 vs 2032 年

第四章急性肾损伤治疗市场：宏观分析与市场动态

  • 介绍
  • 2022-2032年全球急性肾损伤治疗市场价值
  • 市场动态
    • 市场驱动力
    • 市场制约因素
    • 主要问题
    • 主要机会
  • 促进因素和抑制因素的影响分析
  • 跷跷板分析
  • 波特的五力模型
    • 供应商实力
    • 购买力
    • 替代品的威胁
    • 新进入者的威胁
    • 竞争对手之间的竞争
  • PESTEL 分析
    • 政局
    • 金融情况
    • 技术景观
    • 法律状况
    • 社会局势

第五章急性肾损伤治疗市场：依治疗方法分类2022-2032年

  • 市场概况
  • 成长/利润分析：2023 年与 2032 年
  • 市场细分
    • 透析
    • 支持性护理

第六章 急性肾损伤治疗市场：依类型 2022-2032

  • 市场概况
  • 成长/利润分析：2023 年与 2032 年
  • 市场细分
    • 肾前性急性肾损伤
    • 内源性肾性急性肾损伤
    • 肾后性急性肾损伤

第七章 急性肾损伤治疗市场：依最终使用者分类 2022-2032

  • 市场概况
  • 成长/利润分析：2023 年与 2032 年
  • 市场细分
    • 医院
    • 门诊手术中心
    • 其他

第8章 2022-2032年北美急性肾损伤治疗市场

  • 市场概况
  • 急性肾损伤治疗市场：依治疗方法分类 2022-2032
  • 急性肾损伤治疗市场：依类型 2022-2032
  • 急性肾损伤治疗市场：依最终使用者分类 2022-2032
  • 急性肾损伤治疗市场：依地区划分 2022-2032
    • 北美
      • 美国
      • 加拿大
      • 其他北美

第9章英国及欧盟急性肾损伤治疗市场2022-2032

  • 市场概况
  • 急性肾损伤治疗市场：依治疗方法分类 2022-2032
  • 急性肾损伤治疗市场：依类型 2022-2032
  • 急性肾损伤治疗市场：依最终使用者分类 2022-2032
  • 急性肾损伤治疗市场：依地区划分 2022-2032
    • 英国和欧盟
      • 英国
      • 德国
      • 西班牙
      • 义大利
      • 法国
      • 欧洲其他地区

第10章 2022-2032年亚太地区急性肾损伤治疗市场

  • 市场概况
  • 急性肾损伤治疗市场：依治疗方法划分2022-2032年
  • 急性肾损伤治疗市场：依类型 2022-2032
  • 急性肾损伤治疗市场：依最终使用者分类 2022-2032
  • 急性肾损伤治疗市场：依地区划分 2022-2032
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 亚太其他地区

第十一章拉丁美洲急性肾损伤治疗市场2022-2032

  • 市场概况
  • 急性肾损伤治疗市场：依治疗方法分类 2022-2032
  • 急性肾损伤治疗市场：依类型 2022-2032
  • 急性肾损伤治疗市场：依最终使用者分类 2022-2032
  • 急性肾损伤治疗市场：依地区划分 2022-2032
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地区

第12章 2022-2032年中东及非洲急性肾损伤治疗市场

  • 市场概况
  • 急性肾损伤治疗市场：依治疗方法分类 2022-2032
  • 急性肾损伤治疗市场：依类型 2022-2032
  • 急性肾损伤治疗市场：依最终使用者分类 2022-2032
  • 急性肾损伤治疗市场：依地区划分 2022-2032
    • 中东/非洲
      • 海湾合作委员会
      • 非洲
      • 其他中东/非洲地区

第十三章公司简介

  • Fresenius Medical Care AG & Co. KGaA
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Angion Biomedica Corp.
  • AM-Pharma
  • Quark Pharmaceuticals Inc.
  • Asahi Kasei Medical Co. Ltd.
  • LG Chem
  • 其他主要公司
Product Code: 140195-03-24

The acute kidney injury treatment market is expected to grow at a CAGR of 7.8% during the forecast period of 2024 to 2032, influenced by various drivers and segmented aspects. Three key drivers fuelling market growth include the increasing prevalence of acute kidney injury, advancements in treatment modalities, and a rising geriatric population. These factors contribute to a positive outlook for the market, with a forecasted surge in demand for effective AKI treatments. Competitive trends showcase the prowess of key players like Fresenius Medical Care AG & Co. KGaA, Baxter International Inc., and B. Braun Melsungen AG. Their strategic initiatives, encompassing research and development, partnerships, and technological integration, underscore a vibrant and evolving market. These companies position themselves strategically to address challenges and capitalize on emerging opportunities, shaping the future trajectory of the Acute kidney injury treatment market.

Key Market Drivers

Advancements in Dialysis Technologies

The dialysis segment of the Acute kidney injury treatment market has experienced substantial growth, attributed to continuous advancements in dialysis technologies. In 2023, the market witnessed a surge in demand for more efficient and patient-friendly dialysis methods. Innovations such as wearable and portable dialysis devices gained traction, enhancing treatment accessibility and improving the quality of life for AKI patients. Evidence suggests a positive correlation between the adoption of advanced dialysis technologies and increased patient satisfaction.

Rising Focus on Supportive Care

Supportive care emerged as a pivotal driver in the Acute kidney injury treatment market, responding to the need for comprehensive patient management. The paradigm shifts towards holistic patient care, beyond traditional medical interventions, contributed to the prominence of supportive care. In 2023, evidence indicated a growing recognition of the importance of psychosocial support, nutritional interventions, and symptom management in improving AKI patient outcomes. Supportive care strategies demonstrated not only enhanced patient well-being but also potential cost-effectiveness.

Segmentation by AKI Type

Market segmentation based on AKI types, including Pre-renal AKI, Intrinsic Renal AKI, and Post-renal AKI, played a pivotal role in tailoring treatment approaches. In 2023, the highest revenue was observed in the Pre-renal AKI segment, reflecting the prevalence of conditions leading to reduced blood flow to the kidneys. Meanwhile, the Intrinsic Renal AKI segment exhibited the highest CAGR during the forecast period, signifying increasing recognition and targeted interventions for intrinsic kidney issues.

Challenges in Post-AKI Recovery

While advancements in acute treatment modalities are notable, the market faces a significant restraint concerning post-AKI recovery. In 2023, evidence pointed towards limited success in achieving complete recovery and preventing chronic kidney disease progression in some patients post-AKI. Despite acute treatment efficacy, the long-term impact and sustainable recovery remain areas of concern, posing challenges for both healthcare providers and patients.

Market by Treatment: Dialysis Dominate the Market

The market is primarily segmented into Dialysis and Supportive Care. In 2023, Dialysis emerged as the dominant treatment modality, capturing both the highest revenue and exhibiting the highest Compound Annual Growth Rate (CAGR) during the forecast period of 2024 to 2032. Dialysis, including hemodialysis and peritoneal dialysis, is instrumental in addressing the immediate complications associated with AKI, providing a crucial lifeline for patients.

Market by Type: Pre-renal AKI Segment Dominate the Market

AKI is classified into various types, including Pre-renal AKI, Intrinsic Renal AKI, and Post-renal AKI. The Pre-renal AKI segment commanded the highest revenue in 2023, indicating the prevalence of conditions leading to decreased blood flow to the kidneys, such as dehydration or heart failure. Concurrently, the Intrinsic Renal AKI segment exhibited the highest CAGR during the forecast period, highlighting the growing recognition and targeted interventions for intrinsic kidney issues, such as acute tubular necrosis.

Market by End-user: Hospitals Dominate the Market

End-user segmentation encompasses Hospitals, Ambulatory Surgical Centers (ASCs), and Other healthcare settings. Hospitals emerged as the leading end-user in 2023, both in terms of revenue and CAGR. The hospital setting is pivotal for managing acute cases of kidney injury, providing specialized care, and access to advanced treatment modalities. Ambulatory Surgical Centers and other healthcare facilities also play crucial roles in specific scenarios, contributing to the overall landscape of AKI treatment.

North America remains the Global Leader

The geographic segment analysis reveals compelling trends, reflecting regional variations in AKI prevalence, healthcare infrastructure, and treatment accessibility. Asia-Pacific demonstrated the highest CAGR in the Acute kidney injury treatment market. This growth is attributed to increased awareness, improved healthcare infrastructure, and a higher prevalence of conditions leading to AKI. The dynamic nature of this region's healthcare landscape positions it as a key player in the future trajectory of AKI treatment. In terms of revenue percentage, North America led the market in 2023. The dominance of this region is fueled by factors such as a large patient population, well-established healthcare facilities, and a proactive approach to AKI management. Understanding the regional nuances is crucial for stakeholders aiming to capitalize on emerging opportunities and address specific challenges in diverse healthcare ecosystems.

Market Competition to Intensify during the Forecast Period

In 2023, the Acute kidney injury treatment market witnessed prominent performances from key players, including Fresenius Medical Care AG & Co. KGaA, Baxter International Inc., B. Braun Melsungen AG, Angion Biomedica Corp., AM-Pharma, Quark Pharmaceuticals, Inc., Asahi Kasei Medical Co., Ltd., and LG Chem. These industry leaders strategically implemented initiatives such as research and development, partnerships, and geographical expansion to reinforce their market positions. Notably, Fresenius Medical Care AG & Co. KGaA emphasized cutting-edge technologies, while Baxter International Inc. focused on patient-centric approaches. Additionally, B. Braun Melsungen AG contributed significantly to market dynamics through strategic initiatives, including mergers and acquisitions and quality improvement. This highlights the vibrant and evolving competitive landscape in the Acute kidney injury treatment market.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Acute Kidney Injury Treatment market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report

Micro and macro environment factors that are currently influencing the Acute Kidney Injury Treatment market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Treatment

    • Dialysis
    • Supportive Care

Type

    • Pre-renal Acute Kidney Injury
    • Intrinsic Renal Acute Kidney Injury
    • Post-renal Acute Kidney Injury

End-User

    • Hospitals
    • Ambulatory Surgical Centers
    • Others

Region Segment (2022-2032; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of Acute Kidney Injury Treatment market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2032.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Acute Kidney Injury Treatment market?

Which is the largest regional market for Acute Kidney Injury Treatment market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Acute Kidney Injury Treatment market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Acute Kidney Injury Treatment market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Acute Kidney Injury Treatment Market
  • 2.2. Global Acute Kidney Injury Treatment Market, By Treatment, 2023 (US$ Million)
  • 2.3. Global Acute Kidney Injury Treatment Market, By Type, 2023 (US$ Million)
  • 2.4. Global Acute Kidney Injury Treatment Market, By End-User, 2023 (US$ Million)
  • 2.5. Global Acute Kidney Injury Treatment Market, By Geography, 2023 (US$ Million)
  • 2.6. Attractive Investment Proposition by Geography, 2023

3. Acute Kidney Injury Treatment Market: Competitive Analysis

  • 3.1. Market Positioning of Key Acute Kidney Injury Treatment Market Vendors
  • 3.2. Strategies Adopted by Acute Kidney Injury Treatment Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2023 Versus 2032

4. Acute Kidney Injury Treatment Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Acute Kidney Injury Treatment Market Value, 2022 - 2032, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 5.3. Market Segmentation
    • 5.3.1. Dialysis
    • 5.3.2. Supportive Care

6. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 6.3. Market Segmentation
    • 6.3.1. Pre-renal Acute Kidney Injury
    • 6.3.2. Intrinsic Renal Acute Kidney Injury
    • 6.3.3. Post-renal Acute Kidney Injury

7. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 7.3. Market Segmentation
    • 7.3.1. Hospitals
    • 7.3.2. Ambulatory Surgical Centers
    • 7.3.3. Others

8. North America Acute Kidney Injury Treatment Market, 2022-2032, USD (Million)

  • 8.1. Market Overview
  • 8.2. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
  • 8.3. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
  • 8.4. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
  • 8.5.Acute Kidney Injury Treatment Market: By Region, 2022-2032, USD (Million)
    • 8.5.1.North America
      • 8.5.1.1. U.S.
        • 8.5.1.1.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 8.5.1.1.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 8.5.1.1.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
      • 8.5.1.2. Canada
        • 8.5.1.2.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 8.5.1.2.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 8.5.1.2.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
      • 8.5.1.3. Rest of North America
        • 8.5.1.3.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 8.5.1.3.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 8.5.1.3.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)

9. UK and European Union Acute Kidney Injury Treatment Market, 2022-2032, USD (Million)

  • 9.1. Market Overview
  • 9.2. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
  • 9.3. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
  • 9.4. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
  • 9.5.Acute Kidney Injury Treatment Market: By Region, 2022-2032, USD (Million)
    • 9.5.1.UK and European Union
      • 9.5.1.1. UK
        • 9.5.1.1.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 9.5.1.1.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 9.5.1.1.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
      • 9.5.1.2. Germany
        • 9.5.1.2.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 9.5.1.2.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 9.5.1.2.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
      • 9.5.1.3. Spain
        • 9.5.1.3.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 9.5.1.3.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 9.5.1.3.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
      • 9.5.1.4. Italy
        • 9.5.1.4.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 9.5.1.4.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 9.5.1.4.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
      • 9.5.1.5. France
        • 9.5.1.5.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 9.5.1.5.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 9.5.1.5.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
      • 9.5.1.6. Rest of Europe
        • 9.5.1.6.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 9.5.1.6.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 9.5.1.6.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)

10. Asia Pacific Acute Kidney Injury Treatment Market, 2022-2032, USD (Million)

  • 10.1. Market Overview
  • 10.2. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
  • 10.3. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
  • 10.4. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
  • 10.5.Acute Kidney Injury Treatment Market: By Region, 2022-2032, USD (Million)
    • 10.5.1.Asia Pacific
      • 10.5.1.1. China
        • 10.5.1.1.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 10.5.1.1.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 10.5.1.1.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
      • 10.5.1.2. Japan
        • 10.5.1.2.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 10.5.1.2.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 10.5.1.2.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
      • 10.5.1.3. India
        • 10.5.1.3.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 10.5.1.3.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 10.5.1.3.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
      • 10.5.1.4. Australia
        • 10.5.1.4.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 10.5.1.4.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 10.5.1.4.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
      • 10.5.1.5. South Korea
        • 10.5.1.5.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 10.5.1.5.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 10.5.1.5.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
      • 10.5.1.6. Rest of Asia Pacific
        • 10.5.1.6.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 10.5.1.6.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 10.5.1.6.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)

11. Latin America Acute Kidney Injury Treatment Market, 2022-2032, USD (Million)

  • 11.1. Market Overview
  • 11.2. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
  • 11.3. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
  • 11.4. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
  • 11.5.Acute Kidney Injury Treatment Market: By Region, 2022-2032, USD (Million)
    • 11.5.1.Latin America
      • 11.5.1.1. Brazil
        • 11.5.1.1.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 11.5.1.1.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 11.5.1.1.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
      • 11.5.1.2. Mexico
        • 11.5.1.2.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 11.5.1.2.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 11.5.1.2.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
      • 11.5.1.3. Rest of Latin America
        • 11.5.1.3.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 11.5.1.3.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 11.5.1.3.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)

12. Middle East and Africa Acute Kidney Injury Treatment Market, 2022-2032, USD (Million)

  • 12.1. Market Overview
  • 12.2. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
  • 12.3. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
  • 12.4. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
  • 12.5.Acute Kidney Injury Treatment Market: By Region, 2022-2032, USD (Million)
    • 12.5.1.Middle East and Africa
      • 12.5.1.1. GCC
        • 12.5.1.1.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 12.5.1.1.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 12.5.1.1.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
      • 12.5.1.2. Africa
        • 12.5.1.2.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 12.5.1.2.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 12.5.1.2.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
      • 12.5.1.3. Rest of Middle East and Africa
        • 12.5.1.3.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
        • 12.5.1.3.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
        • 12.5.1.3.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)

13. Company Profile

  • 13.1. Fresenius Medical Care AG & Co. KGaA
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Portfolio
    • 13.1.4. Strategic Initiatives
  • 13.2. Baxter International Inc.
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Portfolio
    • 13.2.4. Strategic Initiatives
  • 13.3. B. Braun Melsungen AG
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Portfolio
    • 13.3.4. Strategic Initiatives
  • 13.4. Angion Biomedica Corp.
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Portfolio
    • 13.4.4. Strategic Initiatives
  • 13.5. AM-Pharma
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Portfolio
    • 13.5.4. Strategic Initiatives
  • 13.6. Quark Pharmaceuticals, Inc.
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Portfolio
    • 13.6.4. Strategic Initiatives
  • 13.7. Asahi Kasei Medical Co., Ltd.
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Portfolio
    • 13.7.4. Strategic Initiatives
  • 13.8. LG Chem
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Portfolio
    • 13.8.4. Strategic Initiatives
  • 13.9. Other Notable Players
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Portfolio
    • 13.9.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 2 Global Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 3 Global Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 4 North America Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 5 North America Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 6 North America Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 7 U.S. Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 8 U.S. Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 9 U.S. Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 10 Canada Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 11 Canada Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 12 Canada Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 13 Rest of North America Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 14 Rest of North America Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 15 Rest of North America Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 16 UK and European Union Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 17 UK and European Union Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 18 UK and European Union Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 19 UK Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 20 UK Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 21 UK Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 22 Germany Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 23 Germany Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 24 Germany Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 25 Spain Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 26 Spain Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 27 Spain Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 28 Italy Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 29 Italy Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 30 Italy Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 31 France Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 32 France Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 33 France Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 34 Rest of Europe Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 35 Rest of Europe Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 36 Rest of Europe Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 37 Asia Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 38 Asia Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 39 Asia Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 40 China Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 41 China Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 42 China Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 43 Japan Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 44 Japan Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 45 Japan Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 46 India Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 47 India Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 48 India Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 49 Australia Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 50 Australia Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 51 Australia Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 52 South Korea Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 53 South Korea Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 54 South Korea Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 55 Latin America Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 56 Latin America Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 57 Latin America Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 58 Brazil Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 59 Brazil Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 60 Brazil Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 61 Mexico Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 62 Mexico Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 63 Mexico Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 64 Rest of Latin America Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 65 Rest of Latin America Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 66 Rest of Latin America Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 67 Middle East and Africa Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 68 Middle East and Africa Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 69 Middle East and Africa Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 70 GCC Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 71 GCC Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 72 GCC Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 73 Africa Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 74 Africa Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 75 Africa Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
  • TABLE 76 Rest of Middle East and Africa Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
  • TABLE 77 Rest of Middle East and Africa Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
  • TABLE 78 Rest of Middle East and Africa Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)

List of Figures

  • FIG. 1 Global Acute Kidney Injury Treatment Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Acute Kidney Injury Treatment Market: Quality Assurance
  • FIG. 5 Global Acute Kidney Injury Treatment Market, By Treatment, 2023
  • FIG. 6 Global Acute Kidney Injury Treatment Market, By Type, 2023
  • FIG. 7 Global Acute Kidney Injury Treatment Market, By End-User, 2023
  • FIG. 8 Global Acute Kidney Injury Treatment Market, By Geography, 2023
  • FIG. 9 Market Geographical Opportunity Matrix - Global Acute Kidney Injury Treatment Market, 2023

FIG. 10Market Positioning of Key Acute Kidney Injury Treatment Market Players, 2023

FIG. 11Global Acute Kidney Injury Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032

  • FIG. 12 Global Acute Kidney Injury Treatment Market, By Treatment, 2023 Vs 2032, %
  • FIG. 13 Global Acute Kidney Injury Treatment Market, By Type, 2023 Vs 2032, %
  • FIG. 14 Global Acute Kidney Injury Treatment Market, By End-User, 2023 Vs 2032, %
  • FIG. 15 U.S. Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 16 Canada Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 17 Rest of North America Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 18 UK Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 19 Germany Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 20 Spain Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 21 Italy Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 22 France Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 23 Rest of Europe Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 24 China Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 25 Japan Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 26 India Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 27 Australia Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 28 South Korea Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 29 Rest of Asia Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 30 Brazil Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 31 Mexico Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 32 Rest of Latin America Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 33 GCC Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 34 Africa Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
  • FIG. 35 Rest of Middle East and Africa Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032